Inventor · disambiguated record
Peter Laing
Also filed as: LAING PETER
44 granted patents·14 pending applications·184 citations·filing 1996–2024
98Inventor score
Files withLIPOXEN TECHNOLOGIES LTD14LIPOXEN TECH LTD13JAIN SANJAY7LIPOXEN TECH LIMITED5UNITED THERAPEUTICS CORP5
Top patents by PatentIndex Score
58 records- 0195US9758465B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 12, 2017·24 cites·16 claims
- 0294US10494327B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2017·Granted Dec 3, 2019·11 cites·16 claims
- 0391US8299026B2Derivatisation of erythropoietin (EPO)JAIN SANJAY·Filed 2007·Granted Oct 30, 2012·9 cites·11 claims
- 0491US7604803B2Method to enhance an immune response of nucleic acid vaccinationLIPOXEN TECHNOLOGIES LTD·Filed 2003·Granted Oct 20, 2009·40 cites·10 claims
- 0591US2024343673A1Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0690US9492556B2N-terminal derivatisation of proteins with polysaccharidesLIPOXEN TECH LTD·Filed 2015·Granted Nov 15, 2016·4 cites·19 claims
- 0790US8981050B2N-terminal derivatisation of proteins with polysaccharidesLIPOXEN TECHNOLOGIES LTD·Filed 2013·Granted Mar 17, 2015·5 cites·19 claims
- 0890US8796207B2Derivatisation of erythropoietin (EPO)LIPOXEN TECHNOLOGIES LTD·Filed 2012·Granted Aug 5, 2014·6 cites·9 claims
- 0990US8299015B2Derivatisation of granulocyte colony-stimulating factorJAIN SANJAY·Filed 2007·Granted Oct 30, 2012·6 cites·14 claims
- 1089US8394921B2N-terminal derivatisation of proteins with polysaccharidesJAIN SANJAY·Filed 2007·Granted Mar 12, 2013·6 cites·24 claims
- 1185US11001551B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2019·Granted May 11, 2021·2 cites·10 claims
- 1284US9102714B2Polysialic acid derivativesLIPOXEN TECHNOLOGIES LTD·Filed 2012·Granted Aug 11, 2015·2 cites·15 claims
- 1384US8933026B2Derivatisation of erythropoietin (EPO)LIPOXEN TECHNOLOGIES LTD·Filed 2014·Granted Jan 13, 2015·2 cites·16 claims
- 1483US8828405B2Method to enhance an immune response of nucleic acid vaccinationBACON ANDREW DAVID·Filed 2011·Granted Sep 9, 2014·2 cites·20 claims
- 1583US7807824B2Sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECHNOLOGIES LTD·Filed 2004·Granted Oct 5, 2010·14 cites·26 claims
- 1680US12017989B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2021·Granted Jun 25, 2024·0 cites·6 claims
- 1780US9452224B2Sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LTD·Filed 2014·Granted Sep 27, 2016·3 cites·17 claims
- 1880US9266936B2Derivatisation of erythropoietin (EPO)LIPOXEN TECHNOLOGIES LTD·Filed 2014·Granted Feb 23, 2016·1 cites·11 claims
- 1979US9040478B2Derivatisation of granulocyte colony-stimulating factorLIPOXEN TECHNOLOGIES LTD·Filed 2012·Granted May 26, 2015·1 cites·23 claims
- 2079US8653255B2Sialic acid derivatives for protein derivatisation and conjugationJAIN SANJAY·Filed 2010·Granted Feb 18, 2014·3 cites·13 claims
- 2178US8075896B2Method to enhance an immune response of nucleic acid vaccinationBACON ANDREW DAVID·Filed 2009·Granted Dec 13, 2011·2 cites·20 claims
- 2276US7691826B2Polysialic acid derivativesLIPOXEN TECHNOLOGIES LTD·Filed 2004·Granted Apr 6, 2010·8 cites·14 claims
- 2373US10494449B2Fractionation of charged polysaccharideLIPOXEN TECH LIMITED·Filed 2017·Granted Dec 3, 2019·0 cites·5 claims
- 2473US9486510B2Method to enhance an immune response of nucleic acid vaccinationLIPOXEN TECH LTD·Filed 2014·Granted Nov 8, 2016·0 cites·22 claims
- 2573US9234020B2Derivatisation of erythropoietin (EPO)LIPOXEN TECHNOLOGIES LTD·Filed 2014·Granted Jan 12, 2016·0 cites·17 claims
- 2673US6034066ACysteine protease inhibitors for use in treatment of IGE mediated allergic diseasesPEPTIDE THERAPEUTICS LTD·Filed 1996·Granted Mar 7, 2000·31 cites·14 claims
- 2772US9200052B2Fractionation of charged polysaccharideLIPOXEN TECHNOLOGIES LTD·Filed 2014·Granted Dec 1, 2015·0 cites·35 claims
- 2872US8946406B2Derivatisation of erythropoietin (EPO)LIPOXEN TECHNOLOGIES LTD·Filed 2014·Granted Feb 3, 2015·0 cites·10 claims
- 2971US9750692B2Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvantLIPOXEN TECH LTD·Filed 2014·Granted Sep 5, 2017·1 cites·19 claims
- 3071US8753647B2Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvantBACON ANDREW DAVID·Filed 2006·Granted Jun 17, 2014·1 cites·33 claims
- 3170US9789163B2N-terminal derivatisation of proteins with polysaccharidesLIPOXEN TECH LTD·Filed 2016·Granted Oct 17, 2017·0 cites·6 claims
- 3268US2017080054A1Derivatisation of Granulocyte Colony-Stimulating FactorLIPOXEN TECH LTD·Filed 2016·Application pending·0 cites
- 3368US2017119893A1Derivatisation of Erythropoietin (EPO)LIPOXEN TECH LTD·Filed 2017·Application pending·0 cites
- 3467US9579393B2Derivatisation of erythropoietin (EPO)LIPOXEN TECH LTD·Filed 2016·Granted Feb 28, 2017·0 cites·20 claims
- 3567US9549990B2Derivatisation of erythropoietin (EPO)LIPOXEN TECH LTD·Filed 2016·Granted Jan 24, 2017·0 cites·20 claims
- 3667US9212232B2Reduction of endotoxin in polysialic acidsJAIN SANJAY·Filed 2012·Granted Dec 15, 2015·0 cites·21 claims
- 3766US10301396B2Reduction of endotoxin in polysialic acidsLIPOXEN TECH LIMITED·Filed 2015·Granted May 28, 2019·0 cites·25 claims
- 3865US9920137B2Polysialic acid derivativesLIPOXEN TECH LIMITED·Filed 2015·Granted Mar 20, 2018·0 cites·14 claims
- 3965US9492557B2Derivatisation of granulocyte colony-stimulating factorLIPOXEN TECH LTD·Filed 2015·Granted Nov 15, 2016·0 cites·20 claims
- 4065US9474805B2Derivatisation of granulocyte colony-stimulating factorLIPOXEN TECH LTD·Filed 2015·Granted Oct 25, 2016·0 cites·9 claims
- 4165US2017049702A1Method to Enhance an Immune Response of Nucleic Acid VaccinationLIPOXEN TECH LTD·Filed 2016·Application pending·0 cites
- 4263US8652334B2Fractionation of charged polysaccharideJAIN SANJAY·Filed 2005·Granted Feb 18, 2014·0 cites·36 claims
- 4362US9828443B2Fractionation of charged polysaccharideLIPOXEN TECH LIMITED·Filed 2015·Granted Nov 28, 2017·0 cites·34 claims
- 4462US9790288B2Fractionation of charged polysaccharideLIPOXEN TECH LTD·Filed 2015·Granted Oct 17, 2017·0 cites·30 claims
- 4560US2010221808A1Polysialic acid derivativesLIPOXEN TECHNOLOGIES LTD·Filed 2010·Application pending·0 cites
- 4659US2012121689A1Small interfering rna deliveryBACON ANDREW DAVID·Filed 2009·Application pending·0 cites
- 4758US10406209B2Sialic acid derivatives for protein derivatisation and conjugationLIPOXEN TECH LIMITED·Filed 2016·Granted Sep 10, 2019·0 cites·6 claims
- 4856US2011159130A1Reduction of endotoxin in polysialic acidsJAIN SANJAY·Filed 2008·Application pending·0 cites
- 4955US2006165690A1Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodiesHEATH ANDREW·Filed 2003·Application pending·0 cites
- 5054US2009117135A1Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodiesHEATH ANDREW·Filed 2009·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Laing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →